HIPEC Surgery in India

Top doctors, best hospitals & cost of HIPEC surgery in India. HIPEC surgery for GI cancer patients is best treatment. Call +91 96 1588 1588 for details.

Share This Post

List of Hospitals performing HIPEC Surgery in India

Here’s the list of hospitals performing HIPEC surgery in India.

  • BLK Super Specialty Hospital, New Delhi
  • Global Health City, Chennai
  • Max Hospital, New Delhi
  • Manipal Hospital, Bangalore
  • AIIMS, New Delhi
  • JSS Hospital, Mysuru
  • Fortis, Gurgaon
  • Zydus Hospitals, Ahmedabad
  • H L Hiranandani Hospital, Powai

Doctors performing HIPEC Surgery in India

Here’s the list of doctors who performs HIPEC surgery in India at present –

  • Dr Monika Pansari
  • Dr Rajasundram
  • Dr Surendra Kumar Dabas
  • Dr Vikas Mahajan
  • Dr Nitin Singhal
  • Dr Rahul Chaudhary
  • Dr Chinnababu Sunkavalli

Cost of HIPEC surgery in India

The cost of HIPEC surgery in India depends from patient to patient and on a case to case basis. This surgery can cost anywhere between $ 8000 – $ 20,000 in India.

BEST DOCTORS FOR HIPEC SURGERY IN INDIA

Dr. Monika Pansari is Consultant – Breast, GI & Gynecological Cancer, BGS Gleneagles Global Hospital, Bangalore. She is an expert in performing HIPEC surgery in India. Dr. Monika Pansari is one of the few registered female surgical oncologists in our country with a special interest in breast and gynecological oncology. Her utmost priority being a female onco-surgeon is to help other women fight cancer. She is a specialist in the management of all breast and gynecology cancer surgeries. She completed MBBS and MS (general surgery) from prestigious, Gajra Raja Medical College, Gwalior. She had an excellent academic record throughout and was awarded a university gold medal. Following that she pursued her career in Bangalore and served as assistant Prof. in the department of general surgery in St. Johns medical college for almost 4 years. During this tenure, she underwent training in minimal access surgery and was awarded FIAGES for the same. Subsequently, she pursued DNB in Surgical Oncology from Manipal Hospitals.

Dr. Durgatosh Pandey is HOD & Consultant Surgical Oncology at Artemis Hospital, Gurugram, Delhi (NCR). He worked as Assistant Professor (Surgical Oncology) and In-charge of Thoracic & Hepato-Pancreatic-Biliary service at Institute Rotary Cancer Hospital, AIIMS, New Delhi, Assistant Professor (Surgical Oncology) at Institute of Medical Sciences, Banaras Hindu University, and Specialist Senior Registrar (GI Surgical Oncology): Equivalent to Lecturer at Tata Memorial Hospital, Mumbai. He is Surgical Fellow, Hepatobiliary Surgery & Liver Transplantation (Singapore), Visiting Fellow, Video-Assisted Thoracoscopic Surgery (VATS) & Robotic Thoracic Surgery, 2015 (USA), Founder Member of the Lung Cancer Consortium Asia, Founder member of Esophageal cancer consortium, Trustee member of ICON (Indian Co-operative Oncology Network), External examiner for M.Ch (Surgical Oncology) examination at Tata Memorial Hospital. He is an expert in HIPEC surgery.

Dr. Vikas Mahajan is a Surgical Oncologist in Teynampet, Chennai and has an experience of 23 years in this field. Dr. Vikas Mahajan practices at Apollo Speciality Cancer Hospital in Teynampet, Chennai. He completed MBBS from G B Pant Hospital / Moulana Azad Medical College, New Delhi in 1989, MS – General Surgery from Pt. Deen Dayal Upadhyaya Institute for the Physically Handicapped, New Delhi in 1993 and MCh – Surgical Oncology from The Tamil Nadu Dr. M.G.R. Medical University (TNMGRMU) in 1996.

He is a member of the Indian Medical Association (IMA). Some of the services provided by the doctor are Giant Cell tumour Treatment, Ewing’s Sarcoma Treatment, Breast Cancer Treatment, Prostate cancer, Liver cancer, Stomach cancer, Head and Neck Tumor / Cancer Surgery, and Parotid Surgery, etc. He is among the board trustees of Cancer Fondation (Holistic Cancer Care) in Chennai. Dr Vikas is among the pioneers to start HIPEC surgery in India.

Dr.Rahul Chaudhary – Kolkata did his DNB in Surgical Oncology from a reputed institute. He has fellowships in GI Surgical Oncology and HPB Oncology from prestigious institutes in India & Abroad. Having worked in different parts of the country, he has holistic training in surgical oncology. His vast areas of expertise in surgery include head & neck cancer, breast cancer, gynecological, oesophageal and thoracic malignancies. One of his skills also includes performing laparoscopic-surgery for GI Cancer. His special interest includes areas such as hepatobiliary pancreatic malignancies with extensive work in Gallbladder Cancer. He has multiple publications in Peer-reviewed National & International Journals.

Dr. Chinnababu Sunkavalli is a practicing Surgical oncologist(Cancer Surgeon) at Apollo Hospitals, Jubilee Hills, Hyderabad. He has been practicing as a Surgical Oncologist since 2007 and has performed various operations on my patients from different parts of the world. I am a qualified Surgical Oncologist with a special interest in Organ preservation and Minimally Invasive Surgery. His primary interests are in Cancer surgery of the breast, Head and Neck and G.I Surgery, gynecological surgery, reconstruction of head and neck with microvascular free flaps. My aim is to provide world-class cancer surgery to my patients in accredited hospital facilities.

Dr. Surendra Kumar Dabas is presently working as a Director – Surgical Oncology & Chief – Robotic Surgery at BLK Super Speciality Hospital, New Delhi. Dr. Surender Kumar Dabas has a vast experience in Oncology. He is a pioneer of Robotic Head and Neck Surgery in India and an International mentor of Robotic Surgery. His clinical focus is on Head and Neck Oncology, Trans – Oral Robotic Surgery, Robotic GI Surgery, Thoracic Surgery, and Gynecological Surgery. He has been actively involved in teaching Robotic Surgery across India. He has done a maximum number of Robotic Head and Neck Surgery in Asia. He has numerous National and International publications.

For details on HIPEC Surgery, do call us at +91 96 1588 1588 or write to cancerfax@gmail.com.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer
Colon cancer

Adagrasib with cetuximab has received accelerated approval by FDA for KRAS G12C-mutated colorectal cancer

The FDA has granted accelerated approval to Adagrasib combined with Cetuximab for treating KRAS G12C-mutated colorectal cancer. This approval is based on promising clinical trial results showing enhanced efficacy of the drug duo. Adagrasib, a KRAS inhibitor, and Cetuximab, an EGFR inhibitor, together target the cancer more effectively, offering new hope for patients with this specific genetic mutation, aiming to improve survival rates and treatment outcomes.

Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma
Endometrial cancer

Pembrolizumab with chemotherapy is approved by the USFDA for primary advanced or recurrent endometrial carcinoma

The USFDA has approved Pembrolizumab combined with chemotherapy for treating primary advanced or recurrent endometrial carcinoma. This approval is based on clinical trial data showing significant improvements in patient outcomes. Pembrolizumab, an immune checkpoint inhibitor, works by enhancing the body’s immune response against cancer cells. This combination therapy offers a new and promising treatment option for patients facing this challenging and often aggressive cancer.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy